The role of myelin damage in Alzheimer's disease pathology
Frontiers | Ophthalmic Biomarkers for Alzheimer's Disease: A Review
Refining the amyloid β peptide and oligomer fingerprint ambiguities in Alzheimer's disease: Mass spectrometric molecular characterization in brain, cerebrospinal fluid, blood, and plasma - Michno - 2021 - Journal of Neurochemistry - Wiley Online Library
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Mechanism of amyloid-β (Aβ) removal via Aβ-specific antibodies. FcR =... | Download Scientific Diagram
Clinically accurate diagnosis of Alzheimer's disease via multiplexed sensing of core biomarkers in human plasma | Nature Communications
Biomedicines | Free Full-Text | Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Amyloid β toxic conformer has dynamic localization in the human inferior parietal cortex in absence of amyloid plaques | Scientific Reports
Frontiers | Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer's Disease
Amyloid Beta and Tau Cooperate to Cause Reversible Behavioral and Transcriptional Deficits in a Model of Alzheimer's Disease - ScienceDirect
New Alzheimer's Biomarkers may Support Early Diagnosis
Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease | Nature Medicine
Evaluating Amyloid-β Oligomers in Cerebrospinal Fluid as a Biomarker for Alzheimer's Disease | PLOS ONE
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Dendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models: Cell
Cells | Free Full-Text | Circular RNA Encoded Amyloid Beta peptides—A Novel Putative Player in Alzheimer's Disease
-Immunohistochemistry-Paraffin-NBP2-13075-img0015.jpg "beta Amyloid Antibody (MOAB-2) - BSA Free (NBP2-13075): Novus Biologicals")
beta Amyloid Antibody (MOAB-2) - BSA Free (NBP2-13075): Novus Biologicals
Secreted Amyloid β-Proteins in a Cell Culture Model Include N-Terminally Extended Peptides That Impair Synaptic Plasticity | Biochemistry
Diagnostics | Free Full-Text | Nanobiosensors for Non-Amyloidbeta-Tau Biomarkers as Advanced Reporters of Alzheimer's Disease
Cognitive Decline in Preclinical Alzheimer's Disease: Amyloid-Beta versus Tauopathy - IOS Press
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline? | PLOS Biology
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study - The Lancet Neurology
Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer's disease | Nature Communications
Antibodies against β-Amyloid Slow Cognitive Decline in Alzheimer's Disease: Neuron
